CVKD
Cadrenal Therapeutics, Inc. Common Stock
NASDAQ · Healthcare · Biotechnology · US
$1.22
−4.69%Next report
Analyst consensus
- Next report date
- Nov 9, 2026
- EPS estimate
- -$0.91
- Revenue estimate
- —
Latest reported
- Last report date
- Aug 13, 2026
- EPS actual
- -$1.14
- EPS estimate
- -$1.42
- Revenue actual
- —
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 3
- EPS misses (12Q)
- 5
- EPS in line (12Q)
- 1
- Avg surprise (4Q)
- +0.7%
- Revenue beats (12Q)
- —
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 9, 2026